Context Capital Management’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-121,326
Closed -$1.21M 606
2022
Q3
$1.21M Hold
121,326
0.08% 264
2022
Q2
$1.2M Hold
121,326
0.09% 274
2022
Q1
$1.19M Buy
+121,326
New +$1.19M 0.08% 305

Context Capital Management's FLAC Position: Q4 2022 in Review

Context Capital Management sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 121,326 shares — an estimated $1.21M sold.

Context Capital Management first reported a position in FLAC in Q1 2022 and held it in 3 quarters. The position peaked at $1.21M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

  • Context Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Context Capital Management sold 121,326 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $1.21M.
  • Context Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2022 and held it in 3 quarters.
  • Context Capital Management's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $1.21M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Context Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.